Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
LPAR2 encodes a member of family I of the G protein-coupled receptors, as well as the EDG family of proteins. Additionally we are shipping Lysophosphatidic Acid Receptor 2 Proteins (5) and Lysophosphatidic Acid Receptor 2 Kits (2) and many more products for this protein.
Showing 10 out of 70 products:
Human Polyclonal LPAR2 Primary Antibody for IHC (p), WB - ABIN390085
Horak, Lee, Elkahloun, Boissan, Dumont, Maga, Arnaud-Dabernat, Palmieri, Stetler-Stevenson, Lacombe, Meltzer, Steeg: Nm23-H1 suppresses tumor cell motility by down-regulating the lysophosphatidic acid receptor EDG2. in Cancer research 2007
Show all 4 references for ABIN390085
Human Polyclonal LPAR2 Primary Antibody for WB - ABIN265051
An, Goetzl, Lee: Signaling mechanisms and molecular characteristics of G protein-coupled receptors for lysophosphatidic acid and sphingosine 1-phosphate. in Journal of cellular biochemistry. Supplement 1999
Show all 4 references for ABIN265051
Human Polyclonal LPAR2 Primary Antibody for IF, ELISA - ABIN1535590
Grimwood, Gordon, Olsen, Terry, Schmutz, Lamerdin, Hellsten, Goodstein, Couronne, Tran-Gyamfi, Aerts, Altherr, Ashworth, Bajorek, Black, Branscomb, Caenepeel, Carrano, Caoile, Chan, Christensen et al.: The DNA sequence and biology of human chromosome 19. ... in Nature 2004
LPAR2 signaling is required for in vivo neural crest cell migration.
LPAR2 mRNA is up-regulation in colorectal cancer.
Data show high expression levels of LPAR2 and LPAR1 (show LPAR1 Antibodies) in endometrial cancer tissue with positive correlations with FIGO stage suggesting them as potential biomarkers for endometrial cancer progression.
Suggest that LPA2 and LPA3 (show LPAR3 Antibodies) may function as a molecular switch and play opposing roles during megakaryopoiesis of K562 cells.
the RhoA (show RHOA Antibodies)-regulated formin (show FMN1 Antibodies) Dia1 (show CYB5R3 Antibodies) is involved in entosis downstream of LPAR2
Crystal structure of NHERF2 (show SLC9A3R2 Antibodies) PDZ1 domain complex with C-terminal LPA2 sequence. The PDZ1-LPA2 binding specificity is achieved by hydrogen bonds and hydrophobic contacts with the last four LPA2 residues contributing to specific interactions.
LPA1 (show LPAR1 Antibodies) and LPA2 are major LPA (show APOA Antibodies) receptor subtypes compared with low-expressed LPA3 (show LPAR3 Antibodies) in PANC-1 tumor cells.
Lysophosphatidic acid (LPA) increased hepatocellular carcinoma cells cell invasion, which was LPA-receptor dependent.
LPA2 and LPA6 (show LPAR6 Antibodies) receptor subtypes are predominant in both HPAECs and HMVECs
found that LPA receptor 2/3-mediated IL-8 (show IL8 Antibodies) expression occurs through Gi/PI3K (show PIK3CA Antibodies)/AKT (show AKT1 Antibodies), Gi/PKC (show PRRT2 Antibodies) and IkappaB/NF-kappaB (show NFKB1 Antibodies) signaling
This work shows for the first time that key components of the LPA pathway are modulated following traumatic brain injuries in humans.
Pharmacologic activation of LPA2 attenuates Th2-driven allergic airway inflammation in a mouse model of asthma.
These findings identify ATX (show ENPP2 Antibodies) and LPA2 as radiation-regulated genes that appear to play a physiological role in DNA repair.
Lysophosphatidic acid gradients induce a spatiotemporally restricted decrease in the mobility of LPA receptor 2 (LPA2) on chemotactic fibroblasts.
Lysophosphatidic acid signals through LPA2 receptors and Galphaq (show GNAQ Antibodies) proteins of cultured proximal tubule cells to transactivate latent TGF-beta (show TGFB1 Antibodies) in a Rho/Rho-kinase (show ROCK2 Antibodies) and alphavbeta6 integrin-dependent manner.
these findings identify LPA acting via lpa2 as a novel negative regulatory pathway that inhibits DC activation and allergic airway inflammation.
LPA(1 (show LPAR1 Antibodies)-3) are differentially expressed in the central nervous system and their expression is upregulated in response to injury.
LPA (lysophosphatidic acid) receptors couple to Gq in VSMC (vascular smooth muscle cells)and mediate migration and proliferation which may be mediated through activation of ERK1/2 (show MAPK1/3 Antibodies) and Akt (show AKT1 Antibodies).
lysophosphatidic acid 2 (show PTOV1 Antibodies) receptor mediates down-regulation of Siva-1 (show SIVA1 Antibodies) to promote cell survival
A novel in vivo function for LPA signaling as a germ cell survival factor during spermatogenesis.
Enhanced expression of LPA2 Receptor induce a bypass of p19ARF (show CDKN2A Antibodies)-p53 (show TP53 Antibodies)-dependent senescence.
This gene encodes a member of family I of the G protein-coupled receptors, as well as the EDG family of proteins. This protein functions as a lysophosphatidic acid (LPA) receptor and contributes to Ca2+ mobilization, a critical cellular response to LPA in cells, through association with Gi and Gq proteins. An alternative splice variant has been described but its full length sequence has not been determined.
, GHRH receptor
, GRF receptor
, growth hormone-releasing hormone receptor
, pituitary growth hormone releasing hormone receptor
, G protein-coupled receptor
, LPA receptor 2
, LPA receptor EDG4
, endothelial differentiation, lysophosphatidic acid G-protein-coupled receptor, 4
, lysophosphatidic acid receptor EDG4
, lysophosphatidic acid receptor Edg-4
, endothelial differentiation, lysophosphatidic acid G-protein-coupled receptor 4
, pre-B-cell leukemia transcription factor 4